CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 827 enrolled
Drug / intervention
Multifaceted clinical pharmacy interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04617340
NCT04617340N/ACompleted

The Effect of a trAnSitional Pharmacist Intervention in geRiatric Inpatients on Hospitals Visits After dischargE (ASPIRE): a Randomized Controlled Trial

Universitaire Ziekenhuizen KU Leuven·interventional·Posted Nov 5, 2020·Updated Apr 16, 2025

In Brief

A clinical study evaluating Multifaceted clinical pharmacy intervention for Drug-Related Side Effects and Adverse Reactions. Completed, enrolled 827 participants across 1 site.

Detailed Summary

A randomized controlled trial will be performed in geriatric inpatients to investigate the impact of a multifaceted clinical pharmacy intervention on health related outcomes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBelgium
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedNov 5, 2020
Enrollment StartFeb 25, 2021
Primary CompletionSep 27, 2024
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 5.7 years ago

Interventions

Multifaceted clinical pharmacy interventionother

1. Assessing patient and caregiver preferences 2. Medication reconciliation on admission 3. Performing a comprehensive medication review before discharge 4. Promoting safe transition 4.a. Compiling a patient friendly medication list 4.b.Optimizing communication with healthcare providers in primary care: 4.b.i.Providing a copy of the medication list for the community pharmacist 4.b.ii. Contacting the general practitioner by phone 4.b.iii. Contacting, if applicable the home care nurse or the nurse from the nursing home by phone. 5.A motivation interview will take place before discharge with patients and caregivers 6.Post-discharge follow-up: 6.a.Follow-up call to discuss potential drug therapy issues, therapy adherence and to resolve any pending issues 6.b.A telepharmacology service will be provided to primary healthcare professionals as a means to consult the ward-based clinical pharmacists and/or research team after discharge.